Market capitalization
96.28 BZAR
1.58%
20
11ZAR
5.23 BZAR
40.71 BZAR
356.08 M
Beta (1Y)
0.58
About ASPEN PHARMACARE HLDGS LTD
Sector
CEO
Stephen Bradley Saad
Headquarters
Durban
Website
Employees (FY)
9.16 K
Founded
1850
ISIN
ZAE000066692
FIGI
BBG000BP97L3
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
0.00
$JSEAPN Hitting Double Resistance on the Weekly
Short
Aspen Seeking to Push into Weekly Cycle HighAspen is consolidating in a symmetrical triangle, it has good support in the triangle and the median line of Pitchfork. On the weekly perspective we are in time for a half cycle correction hence I expect the price to resolve upwards. The stop-loss is R185.41
Long
UPDATE: Target Reached Aspen R206.03 - Next target higherSymmetrical Triangle was a a text book trade. The previous trend was up. Price broke above the apex 3/4s in and the momentum continued up. We had further indicators of confirmation for upside to come.Price>20Price>200 Target 1 R206.03So what now? Well we can expect somewhat a consolidation, an
Long
Our opinion on the current state of APNAspen Pharmacare Holdings Limited (APN), a leading pharmaceutical company, operates globally, distributing its products across 150 countries. The company's diversified product range targets various acute and chronic medical conditions, with a focus on thrombosis, anaesthetics, cytotoxics, and nutrit
$JSEAPN - Aspen: Double Bottom Target Reached, What Now?See link below for previous analysis.Aspen reached the target price of 20400 cps and momentum still looks strong.I will look for dips above 18286 for new long entries
Aspen breakoutJSE:APN breakout happened last week. It could be the start of a good thing. Fingers crossed. Manage risk accordingly.
ASPEN - Area of InterestAspen has reversed pretty much all of the down move after its earnings release in August this year.Does it manage to breakout here or do we see it reset some of this move? The first sign of weakness will be a close below R185. No position.
Aspen With Weekly Low Confirmed (Bullish)Aspen confirmed a weekly after finding support at the 200 week moving average, now price is seeking a half cycle high. On the RSI we can see it reaching an overbought level with TSI stretched to the upside, we can expect a pullback from here while price seeks to cool off the indicators before seekin
Long
Aspen Begins Weekly Cycle DeclineAspen is now in week 24 of a weekly cycle, this is a favourite spot to reach a top, we ended the week with a swing high confirmation. The next task is moving down and closing below the upslopping trendline. The red arrow shows the likely path the share is going to follow on the way down. The 200 wee
Short
$JSEAPN - Aspen Pharmacare: Short-term Double Bottom BuyI do not have a high conviction long-term wave count for Aspen.A quick glance at the chart shows a potential double bottom at the 16100 region.The stock looks to have caught a bid with volume increasing from the October 26 low.The double bottom will be confirmed by a break above 18286 but aggres
Long
Keep reading
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of
APN
is
21429
ZAC
— it has increased by
0.26
% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on
JSE
exchange
ASPEN PHARMACARE HLDGS LTD
stocks are traded under the ticker
APN
.
ASPEN PHARMACARE HLDGS LTD
is going to release the next earnings report on
Sep 3, 2024
. Keep track of upcoming events with our Earnings Calendar.
APN
stock is
3.40
% volatile and has beta coefficient of
0.58
. Check out the list of the most volatile stocks — is
ASPEN PHARMACARE HLDGS LTD
there?
for the last quarter amounts to
21.56 B
ZAC
despite the estimated figure of
21.21 B
ZAC
. In the next quarter revenue is expected to reach
20.19 B
ZAC
.
Yes, you can track
ASPEN PHARMACARE HLDGS LTD financialsin yearly and quarterly reports right on TradingView.
APN
stock has fallen by
4.76
% compared to the previous week, the month change is a
0.79
% fall, over the last year
ASPEN PHARMACARE HLDGS LTD
has showed a
15.83
% increase.
APN
net income for the last quarter is
2.31 B
ZAR
, while the quarter before that showed
2.55 B
ZAR
of net income which accounts for
−9.40
% change. Track more
ASPEN PHARMACARE HLDGS LTD financial statsto get the full picture.
Today
ASPEN PHARMACARE HLDGS LTD
has the market capitalization of
94.95 B
, it has decreased by
3.00
% over the last week.
Yes,
APN
dividends are paid annually. The last dividend per share was
3.42
ZAR
. As of today, Dividend Yield (TTM)% is
1.60
%. Tracking
ASPEN PHARMACARE HLDGS LTD dividendsmight help you take more informed decisions.
ASPEN PHARMACARE HLDGS LTD
dividend yield was
1.86
% in
2023
, and payout ratio reached
29.06
%. The year before the numbers were
2.34
% and
22.76
% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks,
APN
shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade
ASPEN PHARMACARE HLDGS LTD
stock right from TradingView charts — choose your broker and connect to your account.
APN
reached its all-time high on
Jan 27, 2015
with the price of
44868
ZAC
, and its all-time low was
629
ZAC
and was reached on
Mar 17, 2003
.
See other stocks reaching their highest and lowest prices.
As of
Apr 24, 2024
, the company has
9.16 K
employees. See our rating of the largest employees — is
ASPEN PHARMACARE HLDGS LTD
on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So
ASPEN PHARMACARE HLDGS LTD
technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating
ASPEN PHARMACARE HLDGS LTD
stock shows the buy signal. See more of
ASPEN PHARMACARE HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on
ASPEN PHARMACARE HLDGS LTD
future price: according to them,
APN
price has a max estimate of
25000.00
ZAC
and a min estimate of
20100.00
ZAC
. Read a more detailed
ASPEN PHARMACARE HLDGS LTD forecast: see what analysts think of
ASPEN PHARMACARE HLDGS LTD
and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company.
ASPEN PHARMACARE HLDGS LTD
EBITDA is
11.35 B
ZAR
, and current EBITDA margin is
26.42
%. See more stats in
ASPEN PHARMACARE HLDGS LTD financial statements.
